Baird Financial Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,890
Closed -$212K 1799
2025
Q1
$212K Buy
2,890
+40
+1% +$3.31K ﹤0.01% 1673
2024
Q4
$236K Sell
2,850
-193
-6% -$15.2K ﹤0.01% 1632
2024
Q3
$218K Sell
3,043
-203
-6% -$14.3K ﹤0.01% 1645
2024
Q2
$222K Buy
+3,246
New +$194K ﹤0.01% 1645
2023
Q3
Sell
-3,731
Closed -$222K 1732
2023
Q2
$222K Sell
3,731
-39
-1% -$2.22K ﹤0.01% 1586
2023
Q1
$214K Sell
3,770
-128
-3% -$8.21K ﹤0.01% 1602
2022
Q4
$289K Buy
+3,898
New +$265K ﹤0.01% 1467
2016
Q3
Sell
-1,077,793
Closed -$25.7M 1204
2016
Q2
$25.7M Sell
1,077,793
-251,793
-19% -$6.04M 0.24% 128
2016
Q1
$31.6M Sell
1,329,586
-33,727
-2% -$824K 0.3% 97
2015
Q4
$37.9M Sell
1,363,313
-40,687
-3% -$1.02M 0.38% 66
2015
Q3
$29M Buy
1,404,000
+445,362
+46% +$11.3M 0.31% 91
2015
Q2
$24.6M Buy
+958,638
New +$24.3M 0.24% 124

Other funds holding GMED

Baird Financial Group's GMED Position: Q2 2025 in Review

Baird Financial Group sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 2,890 shares — an estimated $212K sold.

Baird Financial Group first reported a position in GMED in Q2 2015 and held it in 12 quarters. The position peaked at $37.9M in Q4 2015. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Baird Financial Group reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Baird Financial Group sold 2,890 Globus Medical shares in Q2 2025, an estimated $212K.
  • Baird Financial Group first reported a position in Globus Medical in Q2 2015 and held it in 12 quarters.
  • Baird Financial Group's Globus Medical position peaked at $37.9M in Q4 2015.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Baird Financial Group's 13F filing for Q2 2025, filed 13 Aug 2025.